Oncologists Accepting Humana in Boston, MAPage 2
93 verified oncologists in Boston, Massachusetts accept Humana. Profiles cover focus areas including Medical Oncology, Sarcoma, and Breast Oncology. Common hospital affiliations include Dana-Farber Cancer Institute, Brigham and Women's Hospital, and Massachusetts General Hospital.


Ann Silk, M.D.
Director of the Merkel Cell Carcinoma Center of Excellence; Assistant Professor of Medicine, Harvard Medical School
Oncology


Neil Horowitz, MD
Surgical Director, Gynecologic Oncology; Director, Clinical Research in Gynecologic Oncology; Associate Professor of Obstetrics, Gynecology and Reproductive Biology, Harvard Medical School
Oncology


George Demetri, MD
Professor of Medicine, Harvard Medical School; Director, Sarcoma Center, Dana-Farber Cancer Institute; Senior Vice President for Experimental Therapeutics, Dana-Farber Cancer Institute; Co-Director, Ludwig Center at Dana-Farber/Harvard
Oncology


Leif Ellisen, MD PHD
Professor of Medicine, Harvard Medical School; Program Director, Breast Medical Oncology, Mass General Cancer Center
Oncology


Michael Hassett, M.D., M.P.H.
Chief Resident in Internal Medicine at the University of Rochester in Rochester, NY, he went on to complete a fellowship in Medical Oncology at Dana-Farber
Oncology


Nikhil Munshi, MD
Professor of Medicine, Department of Medicine, Harvard Medical School; Director of Basic and Correlative Science, Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute
Oncology


Irene Ghobrial, M.D.
Senior Vice President for Experimental Medicine, Director of the Center for Early Detection and Interception of Blood Cancers, Co-Leader of the Lymphoma/Myeloma Cancer Center Program, Lavine Family Chair for Preventative Cancer Therapies, Director of the Ghobrial Lab, and Professor of Medicine at Dana-Farber Cancer Institute and Harvard Medical School
Oncology


Raymond Mak, M.D.
Associate Professor of Radiation Oncology at Harvard Medical School and Director of Clinical Innovation and Director of Patient Safety/Quality in the Department of Radia; Director of Patient Safety and Quality, Radiation Oncology
Oncology


Brian Wolpin, M.D.
Director, Gastrointestinal Cancer Center; Director, Hale Family Center for Pancreatic Cancer Research
Oncology


Peter Enzinger, MD
Director, Center for Esophageal and Gastric Cancer; Associate Professor of Medicine, Harvard Medical School; Institute Physician
Oncology


Michael Constantine, M.D.
Director, Medical Oncology, Dana-Farber Brigham Cancer Center at Milford Regional Medical Center
Oncology


Narjust Florez, M.D.
Director of the Cancer Care Access Program and a thoracic medical oncologist at the Dana-Farber Brigham Cancer Center. She completed her internal medicine res; Assistant Professor of Medicine, Harvard Medical School
Oncology


Rameen Beroukhim, MD
Associate Professor of Medicine, Harvard Medical School
Oncology


Marlise Luskin, M.D.
Assistant Professor of Medicine, Harvard Medical School; Senior Physician, Dana-Farber Cancer Institute; Educational Director, Adult Leukemia Program, Dana-Farber Cancer Institute; Associate Program Director, Dana-Farber/Mass General Brigham Hematology/Oncology Fellowship Program
Oncology


Alicia Morgans, MD
Director of the Survivorship Program at Dana-Farber Cancer Institute. A clinician and investigator, she has expertise in clinical trials and patient-reported; Director, Survivorship Program
Oncology


Justine Cohen, DO
Senior Physician; Assistant Professor of Medicine, Harvard Medical School
Oncology


Haeseong Park, MD
Medical Oncology
Oncology


Lakshmi Nayak, M.D.
Director of the Center for CNS Lymphoma at Dana-Farber Cancer Institute in Boston. She is an Associate Professor of Neurology at Harvard Medical School. She r; Director of the Center for Central Nervous System (CNS) Lymphoma
Oncology


William Hahn, MD PHD
Professor of Medicine in the Department of Medical Oncology at Dana-Farber Cancer Institute and Harvard Medical School and an Institute Member of the Broad Ins; Chief Operating and Transformation Officer at the Dana-Farber Cancer Institute.
Oncology


Caroline Block, MD
Chief of Hematology and Medical Oncology, Medical Director of the Breast Clinic, Director of Oncology Clinical Research and Director of the Anticoagulation; Director
Oncology